GNTA:NASDAQ, Genenta Science S.p.A.

Why GNTA stock rose on November 3

Genenta Science S.p.A. rose 18.8% on Tuesday, November 3, 2026, on 249,270 shares, 2.9 times its average daily volume. The headline around the move:

GNTA stock overview

Genenta Science S.p.A. (GNTA:NASDAQ) closed at $0.985 on November 3, 2026, up 18.82% on the day. The stock trades 61.8% below its 52-week high of $2.58 and 79.1% above its 52-week low of $0.550. Genenta Science S.p.A. is part of the Health Care sector.

Key figures

Price
$0.985
Day change
+18.82%
Volume
249,270
Average volume
86,019
Market cap
47M+
52-week range
$0.550 – $2.58
50-day average
$0.746
200-day average
$1.02

Price action over the past year

In 252 trading sessions since November 20, 2025, GNTA closed higher on 101 days (40%). Its best day was June 1, 2026 (+60.19%) and its worst was November 4, 2026 (-28.93%). The stock moved 10% or more in a single session 34 times. It opened at least 5% above the previous day's high 10 times.

GNTA news

About Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company pioneering the development of lentivirus-based first-in-class gene and cell therapies in cancer.

Similar stocks

Find more stocks like GNTA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.